Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Deconinck E

Collect these papers and discover other ones on Labmeeting. Learn more.

Pharmacokinetics of mycophenolic acid administered 3 times daily after hematopoietic stem cell transplantation with reduced-intensity regimen.

+ cite this

+ View Abstract

Royer B, Larosa F, Legrand F, Gerritsen-van Schieveen P, Bérard M, Kantelip JP, and Deconinck E

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 15(9):1134-9, 2009 Sep - Who cited this? | PubMed ID: 19660728 | Fulltext

Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: A case report.

+ cite this

+ View Abstract

Piton G, Larosa F, Minello A, Becker MC, Mantion G, Aubin F, Deconinck E, Hillon P, and Di Martino V

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 15(7):682-5, 2009 Jul - Who cited this? | PubMed ID: 19562700 | Fulltext

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.

+ cite this

+ View Abstract

Garnache-Ottou F, Feuillard J, Ferrand C, Biichle S, Trimoreau F, Seilles E, Salaun V, Garand R, Lepelley P, Maynadié M, Kuhlein E, Deconinck E, Daliphard S, Chaperot L, Beseggio L, Foisseaud V,

(show remaining authors)

British journal of haematology 145(5):624-36, 2009 Jun - Who cited this? | PubMed ID: 19388928 | Fulltext

Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.

+ cite this

+ View Abstract

Kelaidi C, Chevret S, De Botton S, Raffoux E, Guerci A, Thomas X, Pigneux A, Lamy T, Rigal-Huguet F, Meyer-Monard S, Chevallier P, Maloisel F, Deconinck E, Ferrant A, Fegueux N, Ifrah N,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 27(16):2668-76, 2009 Jun 1 - Who cited this? | PubMed ID: 19414681 | Fulltext

[Cord blood grafts: Banking and indications.].

+ cite this

+ View Abstract

Tiberghien P, Chabod J, Deconinck E, and Pouthier F

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 16(2):204-8, 2009 May - Who cited this? | PubMed ID: 19443249 | Fulltext

Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.

+ cite this

+ View Abstract

Kröger N, Brand R, van Biezen A, Zander A, Dierlamm J, Niederwieser D, Devergie A, Ruutu T, Cornish J, Ljungman P, Gratwohl A, Cordonnier C, Beelen D, Deconinck E, Symeonidis A, de Witte T,

(show remaining authors)

Haematologica 94(4):542-9, 2009 Apr - Who cited this? | PubMed ID: 19278968 | Fulltext

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years.

+ cite this

+ View Abstract

Gyan E, Foussard C, Bertrand P, Michenet P, Le Gouill S, Berthou C, Maisonneuve H, Delwail V, Gressin R, Quittet P, Vilque JP, Desablens B, Jaubert J, Ramée JF, Arakelyan N, Thyss A,

(show remaining authors)

Blood 113(5):995-1001, 2009 Jan 29 - Who cited this? | PubMed ID: 18955565 | Fulltext

[Kappa light chain deposition disease, presenting as Sjögren's syndrome, successfully treated by high-dose melphalan and autologous blood stem transplantation.].

+ cite this

+ View Abstract

Foguem C, Kantelip B, Deconinck E, Hafsaoui C, Méaux-Ruault N, Gil H, Magy-Bertrand N, and Dupond JL

La Revue de medecine interne / fondee ... par la Societe nationale francaise de medecine interne 30(1):49-52, 2009 Jan - Who cited this? | PubMed ID: 18801600 | Fulltext

Cost effectiveness of high-dose chemotherapy with autologous stem cell support as initial treatment of aggressive non-Hodgkin's lymphoma.

+ cite this

+ View Abstract

Fagnoni P, Milpied N, Limat S, Deconinck E, Nerich V, Foussard C, Colombat P, Harousseau JL, Woronoff-Lemsi MC, and Groupe Ouest-Est des Leucémies et des Autres Maladies du Sang

PharmacoEconomics 27(1):55-68, 2009 - Who cited this? | PubMed ID: 19178124 | Fulltext

Pharmacokinetic modelling and development of bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation.

+ cite this

+ View Abstract

Saint-Marcoux F, Royer B, Debord J, Larosa F, Legrand F, Deconinck E, Kantelip JP, and Marquet P

Clinical pharmacokinetics 48(10):667-75, 2009 - Who cited this? | PubMed ID: 19743888 | Fulltext

Pharmaceutical aspects of drug eluting stents.

+ cite this

+ View Abstract

Deconinck E, Sohier J, De Scheerder I, and Van den Mooter G

Journal of pharmaceutical sciences 97(12):5047-60, 2008 Dec - Who cited this? | PubMed ID: 18384155 | Fulltext

Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.

+ cite this

+ View Abstract

Chevallier P, Mohty M, Lioure B, Michel G, Contentin N, Deconinck E, Bordigoni P, Vernant JP, Hunault M, Vigouroux S, Blaise D, Tabrizi R, Buzyn A, Socie G, Michallet M, Volteau C,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 26(30):4940-3, 2008 Oct 20 - Who cited this? | PubMed ID: 18606981 | Fulltext

Evaluation of Orthogonal/Dissimilar RP-HPLC Systems Sets for Their Suitability as Method-Development Starting Points for Drug Impurity Profiles.

+ cite this

+ View Abstract

Van Gyseghem E, Deconinck E, Dumarey M, Jimidar M, Sneyers R, Redlich D, Verhoeven E, Peys W, De Smet M, and Vander Heyden Y

Journal of chromatographic science 46(9):793-803, 2008 Oct - Who cited this? | PubMed ID: 19007481 | Fulltext

Isotopic ratios to detect infringements of patents or proprietary processes of pharmaceuticals: two case studies.

+ cite this

+ View Abstract

Deconinck E, van Nederkassel AM, Stanimirova I, Daszykowski M, Bensaid F, Lees M, Martin GJ, Desmurs JR, Smeyers-Verbeke J, and Vander Heyden Y

Journal of pharmaceutical and biomedical analysis 48(1):27-41, 2008 Sep 10 - Who cited this? | PubMed ID: 18562148 | Fulltext

Early immune response against retrovirally transduced herpes simplex virus thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft: an altered immune response?.

+ cite this

+ View Abstract

Mercier-Letondal P, Deschamps M, Sauce D, Certoux JM, Milpied N, Lioure B, Cahn JY, Deconinck E, Ferrand C, Tiberghien P, and Robinet E

Human gene therapy 19(9):937, 2008 Sep - Who cited this? | PubMed ID: 18810797 | Fulltext

Early immune response against retrovirally-transduced Herpes Simplex Virus-thymidine kinase-expressing gene-modified T cells coinfused with a T cell-depleted marrow graft : an altered immune response?.

+ cite this

+ View Abstract

Mercier-Letondal P, Deschamps M, Sauce D, Certoux JM, Milpied N, Lioure B, Cahn JY, Deconinck E, Ferrand C, Tiberghien P, and Robinet E

Human gene therapy, 2008 Aug 5 - Who cited this? | PubMed ID: 18681832 | Fulltext

Exploration of linear multivariate calibration techniques to predict the total antioxidant capacity of green tea from chromatographic fingerprints.

+ cite this

+ View Abstract

Dumarey M, van Nederkassel AM, Deconinck E, and Vander Heyden Y

Journal of chromatography. A 1192(1):81-8, 2008 May 23 - Who cited this? | PubMed ID: 18395730 | Fulltext

Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

+ cite this

+ View Abstract

Michallet M, Le QH, Mohty M, Prébet T, Nicolini F, Boiron JM, Esperou H, Attal M, Milpied N, Lioure B, Bordigoni P, Yakoub-Agha I, Bourhis JH, Rio B, Deconinck E, Renaud M,

(show remaining authors)

Experimental hematology 36(5):535-44, 2008 May - Who cited this? | PubMed ID: 18346838 | Fulltext

Boosted regression trees, multivariate adaptive regression splines and their two-step combinations with multiple linear regression or partial least squares to predict blood-brain barrier passage: a case study.

+ cite this

+ View Abstract

Deconinck E, Zhang MH, Petitet F, Dubus E, Ijjaali I, Coomans D, and Vander Heyden Y

Analytica chimica acta 609(1):13-23, 2008 Feb 18 - Who cited this? | PubMed ID: 18243869 | Fulltext

Statistical confidence for variable selection in QSAR models via Monte Carlo cross-validation.

+ cite this

+ View Abstract

Konovalov DA, Sim N, Deconinck E, Vander Heyden Y, and Coomans D

Journal of chemical information and modeling 48(2):370-83, 2008 Feb - Who cited this? | PubMed ID: 18232680 | Fulltext

Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft.

+ cite this

+ View Abstract

Deschamps M, Mercier-Lethondal P, Certoux JM, Henry C, Lioure B, Pagneux C, Cahn JY, Deconinck E, Robinet E, Tiberghien P, and Ferrand C

Blood 110(12):3842-52, 2007 Dec 1 - Who cited this? | PubMed ID: 17717134 | Fulltext

Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.

+ cite this

+ View Abstract

Baert B, Deconinck E, Van Gele M, Slodicka M, Stoppie P, Bodé S, Slegers G, Vander Heyden Y, Lambert J, Beetens J, and De Spiegeleer B

Bioorganic & medicinal chemistry 15(22):6943-55, 2007 Nov 15 - Who cited this? | PubMed ID: 17827020 | Fulltext

Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.

+ cite this

+ View Abstract

Calmels B, Lemarié C, Esterni B, Malugani C, Charbonnier A, Coso D, de Colella JM, Deconinck E, Caillot D, Viret F, Ladaique P, Lapierre V, and Chabannon C

Transfusion 47(7):1268-75, 2007 Jul - Who cited this? | PubMed ID: 17581163 | Fulltext

Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).

+ cite this

+ View Abstract

Vigouroux S, Michallet M, Porcher R, Attal M, Ades L, Bernard M, Blaise D, Tabrizi R, Garban F, Cassuto JP, Chevalier P, Facon T, Ifrah N, Renaud M, Tilly H, Vernant JP,

(show remaining authors)

Haematologica 92(5):627, 2007 May - Who cited this? | PubMed ID: 17488686 | Fulltext

Evaluation of chromatographic descriptors for the prediction of gastro-intestinal absorption of drugs.

+ cite this

+ View Abstract

Deconinck E, Ates H, Callebaut N, Van Gyseghem E, and Vander Heyden Y

Journal of chromatography. A 1138(1-2):190-202, 2007 Jan 5 - Who cited this? | PubMed ID: 17097093 | Fulltext

Exploration of linear modelling techniques and their combination with multivariate adaptive regression splines to predict gastro-intestinal absorption of drugs.

+ cite this

+ View Abstract

Deconinck E, Coomans D, and Vander Heyden Y

Journal of pharmaceutical and biomedical analysis 43(1):119-30, 2007 Jan 4 - Who cited this? | PubMed ID: 16859855 | Fulltext

Benchmarking of QSAR models for blood-brain barrier permeation.

+ cite this

+ View Abstract

Konovalov DA, Coomans D, Deconinck E, and Heyden YV

Journal of chemical information and modeling 47(4):1648-56, 2007 - Who cited this? | PubMed ID: 17602606 | Fulltext

Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.

+ cite this

+ View Abstract

Adès L, Chevret S, Raffoux E, de Botton S, Guerci A, Pigneux A, Stoppa AM, Lamy T, Rigal-Huguet F, Vekhoff A, Meyer-Monard S, Maloisel F, Deconinck E, Ferrant A, Thomas X, Fegueux N,

(show remaining authors)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 24(36):5703-10, 2006 Dec 20 - Who cited this? | PubMed ID: 17116939 | Fulltext

[Cost of hospital-based management of acute myeloid leukemia: from analytical to procedure-based tarification].

+ cite this

+ View Abstract

Fagnoni P, Limat S, Hintzy-Fein E, Martin F, Deconinck E, Cahn JY, Arveux P, Dussaucy A, and Woronoff-Lemsi MC

Bulletin du cancer 93(8):813-9, 2006 Aug 1 - Who cited this? | PubMed ID: 16935786 | Fulltext

Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.

+ cite this

+ View Abstract

Ducastelle S, Adès L, Gardin C, Dombret H, Prébet T, Deconinck E, Rio B, Thomas X, Debotton S, Guerci A, Gratecos N, Stamatoullas A, Fegueux N, Dreyfus F, Fenaux P, and Wattel E

Haematologica 91(3):373-6, 2006 Mar - Who cited this? | PubMed ID: 16531261 | Fulltext

[Acute leukaemia in two multiple sclerosis patients treated with mitoxantrone].

+ cite this

+ View Abstract

Nollet S, Berger E, Deconinck E, Baldauf E, and Rumbach L

Revue neurologique 162(2):195-9, 2006 Feb - Who cited this? | PubMed ID: 16518259 | Fulltext

Classification tree models for the prediction of blood-brain barrier passage of drugs.

+ cite this

+ View Abstract

Deconinck E, Zhang MH, Coomans D, and Vander Heyden Y

Journal of chemical information and modeling 46(3):1410-9, 2006 - Who cited this? | PubMed ID: 16711761 | Fulltext

Prediction of gastro-intestinal absorption using multivariate adaptive regression splines.

+ cite this

+ View Abstract

Deconinck E, Xu QS, Put R, Coomans D, Massart DL, and Vander Heyden Y

Journal of pharmaceutical and biomedical analysis 39(5):1021-30, 2005 Oct 4 - Who cited this? | PubMed ID: 16040225 | Fulltext

Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis.

+ cite this

+ View Abstract

Millon L, Piarroux R, Deconinck E, Bulabois CE, Grenouillet F, Rohrlich P, Costa JM, and Bretagne S

Journal of clinical microbiology 43(10):5097-101, 2005 Oct - Who cited this? | PubMed ID: 16207969 | Fulltext

Classification of drugs in absorption classes using the classification and regression trees (CART) methodology.

+ cite this

+ View Abstract

Deconinck E, Hancock T, Coomans D, Massart DL, and Heyden YV

Journal of pharmaceutical and biomedical analysis 39(1-2):91-103, 2005 Sep 1 - Who cited this? | PubMed ID: 15946819 | Fulltext

Intensive therapy before or during the conditioning regimen of allogeneic marrow transplantation in adult acute lymphoblastic leukemia patients: we must choose to reduce Toxicity--a Groupe Ouest-Est d'Etude des Leucemies et Autres Maladies du Sang study.

+ cite this

+ View Abstract

Deconinck E, Hunault M, Milpied N, Bernard M, Renaud M, Desablens B, Delain M, Witz F, Lioure B, Pignon B, Guyotat D, Berthou C, Jouet JP, Casassus P, Ifrah N, and Boiron JM

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 11(6):448-54, 2005 Jun - Who cited this? | PubMed ID: 15931633 | Fulltext

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS.

+ cite this

+ View Abstract

Deconinck E, Foussard C, Milpied N, Bertrand P, Michenet P, Cornillet-LeFebvre P, Escoffre-Barbe M, Maisonneuve H, Delwail V, Gressin R, Legouffe E, Vilque JP, Desablens B, Jaubert J, Ramee JF, Jenabian A,

(show remaining authors)

Blood 105(10):3817-23, 2005 May 15 - Who cited this? | PubMed ID: 15687232 | Fulltext

Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation.

+ cite this

+ View Abstract

Larosa F, Marmier C, Robinet E, Ferrand C, Saas P, Deconinck E, Bulabois CE, Rohrlich PS, Ledu K, Helias P, Tiberghien P, and Cahn JY

Bone marrow transplantation 35(9):859-68, 2005 May - Who cited this? | PubMed ID: 15765116 | Fulltext

Cytomegalovirus infection and chronic graft-versus-host disease are significant predictors of renal failure after allogeneic hematopoietic stem cell transplantation.

+ cite this

+ View Abstract

Deconinck E, Kribs M, Rebibou JM, Bulabois CE, Ducloux D, and Cahn JY

Haematologica 90(4):569-70, 2005 Apr - Who cited this? | PubMed ID: 15820963 | Fulltext

Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies.

+ cite this

+ View Abstract

Foussard C, Colombat P, Maisonneuve H, Berthou C, Gressin R, Rousselet MC, Rachieru P, Pignon B, Mahé B, Ghandour C, Desablens B, Casassus P, Lamy T, Delwail V, and Deconinck E

Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 16(3):466-72, 2005 Mar - Who cited this? | PubMed ID: 15695500 | Fulltext

c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome.

+ cite this

+ View Abstract

Valnet-Rabier MB, Challier B, Thiebault S, Angonin R, Margueritte G, Mougin C, Kantelip B, Deconinck E, Cahn JY, and Fest T

British journal of haematology 128(6):767-73, 2005 Mar - Who cited this? | PubMed ID: 15755279 | Fulltext

Expression of the myeloid-associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells.

+ cite this

+ View Abstract

Garnache-Ottou F, Chaperot L, Biichle S, Ferrand C, Remy-Martin JP, Deconinck E, de Tailly PD, Bulabois B, Poulet J, Kuhlein E, Jacob MC, Salaun V, Arock M, Drenou B, Schillinger F, Seilles E,

(show remaining authors)

Blood 105(3):1256-64, 2005 Feb 1 - Who cited this? | PubMed ID: 15388576 | Fulltext

The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study.

+ cite this

+ View Abstract

Sensebé L, Giraudeau B, Bardiaux L, Deconinck E, Schmidt A, Bidet ML, Leniger C, Hardy E, Babault C, and Senecal D

Blood 105(2):862-4, 2005 Jan 15 - Who cited this? | PubMed ID: 15367427 | Fulltext

Cost Effectiveness of Cardioprotective Strategies in Patients with Aggressive Non-Hodgkin's Lymphoma.

+ cite this

+ View Abstract

Limat S, Demesmay K, Fagnoni P, Voillat L, Bernard Y, Deconinck E, Brion A, Arveux P, Cahn JY, and Woronoff-Lemsi MC

Clinical drug investigation 25(11):719-29, 2005 - Who cited this? | PubMed ID: 17532718 | Fulltext

[Economic impact of outpatient chemotherapy in multiple myeloma].

+ cite this

+ View Abstract

Coutet J, Limat S, Voillat L, Deconinck E, Cahn JY, and Woronoff-Lemsi MC

Bulletin du cancer 91(9):729-34, 2004 Sep - Who cited this? | PubMed ID: 15544999 | Fulltext

Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.

+ cite this

+ View Abstract

Rossi JF, van Hoof A, de Boeck K, Johnson SA, Bron D, Foussard C, Lister TA, Berthou C, Kramer MH, Littlewood TJ, Marcus RE, Deconinck E, Montillo M, Guibon O, and Tollerfield SM

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 22(7):1260-7, 2004 Apr 1 - Who cited this? | PubMed ID: 15051774 | Fulltext

Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.

+ cite this

+ View Abstract

Milpied N, Deconinck E, Gaillard F, Delwail V, Foussard C, Berthou C, Gressin R, Lucas V, Colombat P, Harousseau JL, and Groupe Ouest-Est des Leucémies et des Autres Maladies du Sang

The New England journal of medicine 350(13):1287-95, 2004 Mar 25 - Who cited this? | PubMed ID: 15044639 | Fulltext

Renal toxicity after bone marrow transplantation.

+ cite this

Deconinck E and Cahn JY

International journal of radiation oncology, biology, physics 58(3):661-2, 2004 Mar 1 - Who cited this? | PubMed ID: 14967417 | Fulltext

Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome.

+ cite this

+ View Abstract

Depil S, Deconinck E, Milpied N, Sutton L, Witz F, Jouet JP, Damaj G, Yakoub-Agha I, and Société Française de Greffe de Moelle et Thérapie cellulaire

Bone marrow transplantation 33(5):531-4, 2004 Mar - Who cited this? | PubMed ID: 14716345 | Fulltext

A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.

+ cite this

+ View Abstract

Prébet T, Ducastelle S, Debotton S, Stamatoullas A, Deconinck E, Fruchart C, Gratecos N, Ifrah N, Dreyfus F, Fenaux P, Wattel E, and Groupe Français des Myélodysplasies (GFM), France

The hematology journal : the official journal of the European Haematology Association / EHA 5(3):209-15, 2004 - Who cited this? | PubMed ID: 15167906 | Fulltext

Search Google Scholar for Deconinck E

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!